Colin Stoltz Appointed as MIT Co-Director and Leader at Harvard MIT Program in Health Sciences and Technology | MIT news

Colin M. Stoltz, Nina T. and Robert H. Professor of Medical Engineering and Science (IMES), has been appointed effective June 1. IMES is HST’s headquarters at the Massachusetts Institute of Technology.

Stultz is Professor of Electrical Engineering and Computer Science at MIT, core faculty member at IMES, HST faculty member, and practicing cardiologist at Massachusetts General Hospital (MGH). He is also a member of the Electronics Research Laboratory, and an associate member of the Computer Science and Artificial Intelligence Laboratory (CSAIL).

Praised by Anantha B. It undoubtedly helps to enhance and support the missions of both IMES and HST. “

Stultz succeeds Emery N. Brown, who first served as associate director of HST at MIT, following the creation of IMES in 2012. (Wolfram Goessling is co-director of HST at Harvard University.) Brown, Edward Hood Taplin Professor of Medical Engineering and Neuroscience will focus The Massachusetts Institute of Technology (MIT) is now working on creating a new joint center between MIT and MGH that will use the study of anesthesia to design new approaches to controlling brain conditions, with the goal of improving anesthesia and intensive care management.

“He. She It has been a pleasure and an honor to sponsor HST for the past 10 years,” Brown says. “I am sure Colin would be an amazing co-director. He’s a very accomplished scientist, master physician, and committed teacher.”

Says George K. Daly, Dean of Harvard Medical School and HST alumnus, “I am delighted that the new Associate Director of HST is a Harvard Medical School alumni who has completed training and clinical practice at our affiliated hospitals. Dr. Stoltz’s remarkable expertise in computer science and artificial intelligence will make a positive difference as we revitalize This historic collaboration between Harvard and MIT is redefining the scope of what it means to be a medical scientist in the twenty-first century.”

Elazer R. Edelman, Edward J. Poitras Professor of Medical Engineering and Science and Director of IMES, who is also an HST alumnus, praised the appointment, saying: “We are very excited about the future, using Professor Stultz’s incredible vision, his legacy of achievement, his commitment to mentorship, and his innate ability to integrate Excellence in science, medicine, engineering and physiology to drive us forward. Everything that Professor Stultz has done indicates his success and HST.”

Goessling says he is looking forward to working with Stultz in his new role. “I have known Colin since our days at Brigham and Women’s Hospital where we were caring for patients together. I am truly excited to work with him collaboratively and synergistically to nurture our students together, innovate our educational programs, and continue the legacy of success for HST.”

Stultz received a BA honors degree in Mathematics and Philosophy from Harvard University in 1988; Ph.D. in Biophysics from Harvard University in 1997; He received his MD summa cum laude from Harvard Medical School, also in 1997. Stoltz then went on to complete an internship and residency in internal medicine, followed by a fellowship in Cardiovascular Medicine, at Brigham and Women’s Hospital before joining the faculty at Massachusetts Institute of Technology in 2004.

Stoltz once said his research focus at MIT is twofold: “the study of the little things you can’t see with the naked eye, and the study of the big things you can see,” and his scientific contributions have similarly spanned a wide range of length scales. As a graduate student in the lab of Martin Karplus – the 2013 Nobel Prize winner in Chemistry – Stultz helped develop computational methods for designing bonds for flexible protein targets. As a junior faculty member at MIT, his group has leveraged computational biophysics and experimental biochemistry to model disordered proteins that play important roles in human disease. Most recently, his research has focused on the development and application of machine learning methods that enable healthcare providers to gain insight into a patient’s physiology, using clinical data routinely obtained in both clinical and ambulatory settings.

Stultz is a member of the American Society for Biochemistry and Molecular Biology, the Federation of American Societies for Experimental Biology, and a fellow of the American Institute of Medical and Biomedical Engineering. Previously a recipient of the Irving M. London Teaching Award, the CAREER Award from the National Science Foundation, and the Burroughs Wellcome Fund Career Award in Biomedical Sciences, he is a recent visiting scholar from Phi Beta Kappa.

“Following in the footsteps of a famous scientist like Emery Brown is arduous; however, I am very optimistic about what HMS, HST and MIT can achieve in the coming years.” “I look forward to working with Elazer, Anantha, Wolfram, and leadership at HMS to advance the educational mission of HST on the HMS campus and throughout the MIT ecosystem.”